Senior/Principal Bioprocess Engineer

Limerick, County Limerick, Ireland

Auto‑apply with AI Apply

$60,000 – $90,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, Bioprocessing, Chemical EngineeringIndustries

Requirements

Candidates should possess a Bachelor’s degree in Chemical Engineering, Bioprocessing, or a related scientific field, and hold a Master’s degree preferred. They must have at least 8 years of experience in bioprocess engineering, with a strong focus on mammalian cell culture, fermentation, and downstream processing. Demonstrated experience with scale-up and technology transfer is essential, along with a thorough understanding of GMP regulations and cGMP guidelines.

Responsibilities

The Senior/Principal Bioprocess Engineer will provide engineering subject matter expertise to support the design, construction, and preparation for the successful startup of the expanded manufacturing facilities. This includes providing support for design reviews, process safety assessments, User Requirements, C&Q support, Unit Operation Shakedown, and Facility Run Rate Readiness. They will define and own aspects of the Operational Readiness Plan, develop SOPs, support Performance Qualification strategy, lead tech transfer, and work with design and project engineers on verification activities, while also supporting initial Operations Training and alignment of lessons learned.

Skills

Mammalian Cell Culture

Fermentation

Downstream Processing

Scale-up

Technology Transfer

GMP

cGMP

Process Safety

SOPs

Operational Readiness Plan

Verification Activities

Tech Transfer

User Requirements

C&Q

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free